Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dexter

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Participatory Medicine|July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine|March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Parkinson'S Disease|June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopRoger A Barker, Anders Björklund, Don M Gash, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial PlatformCristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Digital Biomarkers|January 14, 2021
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceDiane Stephenson, Robert Alexander, Varun Aggarwal, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Participatory Medicine|July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine|March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Parkinson'S Disease|June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopRoger A Barker, Anders Björklund, Don M Gash, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial PlatformCristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Digital Biomarkers|January 14, 2021
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceDiane Stephenson, Robert Alexander, Varun Aggarwal, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Pageof 7